Welcome to LookChem.com Sign In|Join Free

CAS

  • or
5-Bromo-6-fluoro-1H-indole is a synthetic, organic compound belonging to the class of indoles, characterized by an indole ring system with a chemical formula of C8H5BrFN. It contains carbon, hydrogen, bromine, fluorine, and nitrogen atoms, and has a molecular weight of approximately 227.04 g/mol. As a bromo-fluoro-indole, it exhibits unique properties due to the presence of bromine and fluorine atoms on the indole ring, and is used in various chemical reactions and applications.

434960-42-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 434960-42-6 Structure
  • Basic information

    1. Product Name: 5-bromo-6-fluoro-1H-indole
    2. Synonyms: 5-bromo-6-fluoro-1H-indole;5-Bromo-6-fluoro indole
    3. CAS NO:434960-42-6
    4. Molecular Formula: C8H5BrFN
    5. Molecular Weight: 214.0344032
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 434960-42-6.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 315.9±22.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.750±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: Sealed in dry,Room Temperature
    8. Solubility: N/A
    9. PKA: 15.44±0.30(Predicted)
    10. CAS DataBase Reference: 5-bromo-6-fluoro-1H-indole(CAS DataBase Reference)
    11. NIST Chemistry Reference: 5-bromo-6-fluoro-1H-indole(434960-42-6)
    12. EPA Substance Registry System: 5-bromo-6-fluoro-1H-indole(434960-42-6)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 434960-42-6(Hazardous Substances Data)

434960-42-6 Usage

Uses

Used in Pharmaceutical Industry:
5-Bromo-6-fluoro-1H-indole is used as a pharmaceutical intermediate for the synthesis of complex molecules and drug development. Its unique structure and properties make it a valuable building block in the creation of new pharmaceutical compounds.
Used in Material Science:
In the field of material science, 5-bromo-6-fluoro-1H-indole is utilized for the synthesis of more complex molecules and the development of advanced materials. Its specific reactions and behavior contribute to the design and properties of these materials.
It is important to handle 5-bromo-6-fluoro-1H-indole with caution and follow safety guidelines, as its health effects have not been fully studied.

Check Digit Verification of cas no

The CAS Registry Mumber 434960-42-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,4,9,6 and 0 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 434960-42:
(8*4)+(7*3)+(6*4)+(5*9)+(4*6)+(3*0)+(2*4)+(1*2)=156
156 % 10 = 6
So 434960-42-6 is a valid CAS Registry Number.

434960-42-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Bromo-6-fluoro-1H-indole

1.2 Other means of identification

Product number -
Other names 5-BROMO-6-FLUOROINDOLE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:434960-42-6 SDS

434960-42-6Relevant articles and documents

5-SULFAMOYL-2-HYDROXYBENZAMIDE DERIVATIVES

-

Page/Page column 176, (2017/09/27)

The invention is directed to substituted salicylamide derivatives. Specifically, the invention is directed to compounds according to Formula (I): wherein R, R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof. The compounds of the invention are inhibitors of CD73 and can be useful in the treatment of cancer, pre-cancerous syndromes and diseases associated with CD73 inhibition, such as AIDS, the treatment of HIV, autoimmune diseases, infections, atherosclerosis, and ischemia–reperfusion injury. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting CD73 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

TRICYCLIC SULFONAMIDE DERIVATIVES

-

Paragraph 1013-1015, (2015/07/15)

The invention relates to derivatives of formula (I), wherein the substituents are as defined in the specification; to processes for the preparation of such derivatives; pharmaceutical compositions comprising such derivatives; such derivatives as a medicament; such derivatives for the treatment of pain.

TRICYCLIC SULFONAMIDE DERIVATIVES

-

Page/Page column 120-121, (2015/07/16)

The invention relates to derivatives of formula (I), wherein the substituents are as defined in the specification; to processes for the preparation of such derivatives; pharmaceutical compositions comprising such derivatives; such derivatives as a medicament; such derivatives for the treatment of pain.

SPIRO-SUBSTITUTED OXINDOLE DERIVATIVES HAVING AMPK ACTIVITY

-

Page/Page column 98, (2015/01/07)

The present invention relates to compounds of formula (I), which have valuable pharmacological properties, in particular are activators of AMPK and which are therefore useful in the treatment of certain disorders that can be prevented or treated by activation of this receptor. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.

Positive allosteric modulators of nicotinic acetylcholine receptor

-

Page/Page column 26, (2012/10/08)

The present invention relates to compounds useful in therapy, to compositions comprising said compounds, and to methods of treating diseases comprising administration of said compounds. The compounds referred to are positive allosteric modulators (PAMs) of the nicotinic acetylcholine α7 receptor.

BICYCLIC HETEROARYL COMPOUNDS AS GPR119 RECEPTOR AGONISTS

-

Page/Page column 40, (2012/08/27)

The present invention provides a new class of bicyclic heteroaryl compounds represented by Formula (I), pharmaceutical compositions containing these compounds, and their use for modulating the activity of GPR119 in the treatment of metabolic disorders and complications thereof, as well as methods for the treatment of the metabolic disorders and complications thereof.

NOVEL CYCLIC BENZIMIDAZOLE DERIVATIVES USEFUL AS ANTI-DIABETIC AGENTS

-

Page/Page column 125, (2010/04/25)

Novel compounds of the structural formula (I) are activators of AMP-protein kinase and are useful in the treatment, prevention and suppression of diseases mediated by the AMPK-activated protein kinase. The compounds of the present invention are useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 434960-42-6